{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:59:20Z","timestamp":1781078360997,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Indian Council of Medical Research (ICMR), Government of India","award":["ICMR Grant ID No. Myco\/Adhoc\/4\/2022-ECD-II"],"award-info":[{"award-number":["ICMR Grant ID No. Myco\/Adhoc\/4\/2022-ECD-II"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s11046-026-01074-5","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T08:15:42Z","timestamp":1777277742000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Instability and Subpopulation Dynamics of Azole Trailing Phenotypes in Clinical Candida tropicalis Isolates"],"prefix":"10.1007","volume":"191","author":[{"given":"Snigdha","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saikat","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivaprakash M.","family":"Rudramurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsimran","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anup K.","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"issue":"115","key":"1074_CR1","doi-asserted-by":"publisher","first-page":"e200430","DOI":"10.1590\/0074-02760200430","volume":"9","author":"C Firacative","year":"2020","unstructured":"Firacative C. Invasive fungal disease in humans: are we aware of the real impact? Mem Inst Oswaldo Cruz. 2020;9(115):e200430.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"1074_CR2","doi-asserted-by":"publisher","first-page":"615958","DOI":"10.1155\/2014\/615958","volume":"2014","author":"SC Deorukhkar","year":"2014","unstructured":"Deorukhkar SC, Saini S, Mathew S. Non-albicans Candida infection: an emerging threat. Interdiscip Perspect Infect Dis. 2014;2014:615958.","journal-title":"Interdiscip Perspect Infect Dis"},{"issue":"4","key":"1074_CR3","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1007\/s42770-023-01163-3","volume":"54","author":"RM Abdel-Hamid","year":"2023","unstructured":"Abdel-Hamid RM, El-Mahallawy HA, Abdelfattah NE, Wassef MA. The impact of increasing non-albicans Candida trends on diagnostics in immunocompromised patients. Braz J Microbiol. 2023;54(4):2879\u201392.","journal-title":"Braz J Microbiol"},{"issue":"Suppl 6","key":"1074_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/1469-0691.12539","volume":"20","author":"J Guinea","year":"2014","unstructured":"Guinea J. Global trends in the distribution of Candida species causing candidemia. Clin Microbiol Infect. 2014;20(Suppl 6):5\u201310.","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"1074_CR5","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.3201\/eid2509.190520","volume":"25","author":"P Chen","year":"2019","unstructured":"Chen P, Chuang Y, Wu U, et al. Clonality of fluconazole-nonsusceptible Candida tropicalis in bloodstream infections, Taiwan, 2011\u20132017. Emerg Infect Dis. 2019;25(9):1668\u201375.","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"1074_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jmii.2012.08.025","volume":"47","author":"PY Chen","year":"2014","unstructured":"Chen PY, Chuang YC, Wang JT, Sheng WH, Yu CJ, Chu CC, et al. Comparison of epidemiology and treatment outcome of patients with candidemia at a teaching hospital in Northern Taiwan, in 2002 and 2010. J Microbiol Immunol Infect. 2014;47(2):95\u2013103.","journal-title":"J Microbiol Immunol Infect"},{"issue":"10","key":"1074_CR7","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.cmi.2015.06.010","volume":"21","author":"BH Tan","year":"2015","unstructured":"Tan BH, Chakrabarti A, Li RY, Patel AK, Watcharananan SP, Liu Z, et al. Incidence and species distribution of candidaemia in Asia: a laboratory-based surveillance study. Clin Microbiol Infect. 2015;21(10):946\u201353.","journal-title":"Clin Microbiol Infect"},{"key":"1074_CR8","doi-asserted-by":"crossref","unstructured":"Robbins N, Wright GD, Cowen LE. Antifungal drugs: the current armamentarium and development of new agents. Microbiol Spectr. 2016; 4(5).","DOI":"10.1128\/microbiolspec.FUNK-0002-2016"},{"issue":"1","key":"1074_CR9","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1038\/s41467-018-04926-x","volume":"9","author":"A Rosenberg","year":"2018","unstructured":"Rosenberg A, Ene IV, Bibi M, Zakin S, Segal ES, Ziv N, et al. Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia. Nat Commun. 2018;9(1):2470.","journal-title":"Nat Commun"},{"issue":"12","key":"1074_CR10","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.3390\/jof9121188","volume":"9","author":"I Franconi","year":"2023","unstructured":"Franconi I, Lupetti A. In vitro susceptibility tests in the context of antifungal resistance: beyond minimum inhibitory concentration in Candida spp. J Fungi (Basel). 2023;9(12):1188.","journal-title":"J Fungi (Basel)"},{"key":"1074_CR11","doi-asserted-by":"crossref","unstructured":"Wiederhold NP. Antifungal susceptibility testing: a primer for clinicians. Open Forum Infect Dis. 2021; 8(11):ofab444.","DOI":"10.1093\/ofid\/ofab444"},{"issue":"7","key":"1074_CR12","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/mmy\/myw033","volume":"54","author":"LJ Marcos-Zambrano","year":"2016","unstructured":"Marcos-Zambrano LJ, Escribano P, Sanchez-Carrillo C, Bouza E, Guinea J. Scope and frequency of fluconazole trailing assessed using EUCAST in invasive Candida spp. isolates. Med Mycol. 2016;54(7):733\u20139.","journal-title":"Med Mycol"},{"issue":"4","key":"1074_CR13","doi-asserted-by":"publisher","first-page":"e34609","DOI":"10.1371\/journal.pone.0034609","volume":"7","author":"Y-L Yang","year":"2012","unstructured":"Yang Y-L, Lin C-C, Chang T-P, Lauderdale T-L, Chen H-T, Lee C-F, et al. Comparison of human and soil Candida tropicalis isolates with reduced susceptibility to fluconazole. PLoS ONE. 2012;7(4):e34609.","journal-title":"PLoS ONE"},{"issue":"1","key":"1074_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1128\/CMR.00058-14","volume":"28","author":"OM El-Halfawy","year":"2015","unstructured":"El-Halfawy OM, Valvano MA. Antimicrobial heteroresistance: an emerging field in need of clarity. Clin Microbiol Rev. 2015;28(1):191\u2013207.","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"1074_CR15","doi-asserted-by":"publisher","first-page":"e1007726","DOI":"10.1371\/journal.ppat.1007726","volume":"15","author":"VI Band","year":"2019","unstructured":"Band VI, Weiss DS. Heteroresistance: a cause of unexplained antibiotic treatment failure? PLoS Pathog. 2019;15(6):e1007726.","journal-title":"PLoS Pathog"},{"issue":"4","key":"1074_CR16","doi-asserted-by":"publisher","first-page":"101010","DOI":"10.1016\/j.lanmic.2024.101010","volume":"6","author":"G Heyman","year":"2025","unstructured":"Heyman G, Jonsson S, Fatsis-Kavalopoulos N, Hjort K, Nicoloff H, Furebring M, et al. Prevalence, misclassification, and clinical consequences of the heteroresistant phenotype in Escherichia coli bloodstream infections in patients in Uppsala, Sweden: a retrospective cohort study. Lancet Microbe. 2025;6(4):101010.","journal-title":"Lancet Microbe"},{"issue":"3","key":"1074_CR17","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1172\/JCI124516","volume":"129","author":"NR Stone","year":"2019","unstructured":"Stone NR, Rhodes J, Fisher MC, Mfinanga S, Kivuyo S, Rugemalila J, et al. Dynamic ploidy changes drive fluconazole resistance in human cryptococcal meningitis. J Clin Invest. 2019;129(3):999\u20131014.","journal-title":"J Clin Invest"},{"key":"1074_CR18","doi-asserted-by":"crossref","unstructured":"Ben-Ami R, Zimmerman O, Finn T, Amit S, Novikov A, Wertheimer N, Lurie-Weinberger M, Berman J. Heteroresistance to fluconazole is a continuously distributed phenotype among Candida glabrata clinical strains associated with in vivo persistence. mBio. 2016; 7(4):e00655\u201316.","DOI":"10.1128\/mBio.00655-16"},{"issue":"4","key":"1074_CR19","doi-asserted-by":"publisher","first-page":"e0404123","DOI":"10.1128\/spectrum.04041-23","volume":"12","author":"C Gautier","year":"2024","unstructured":"Gautier C, Maciel EI, Ene IV. Approaches for identifying and measuring heteroresistance in azole-susceptible Candida isolates. Microbiol Spectr. 2024;12(4):e0404123.","journal-title":"Microbiol Spectr"},{"issue":"1","key":"1074_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1590\/S0074-02762012000100005","volume":"107","author":"M Dornelas-Ribeiro","year":"2012","unstructured":"Dornelas-Ribeiro M, Pinheiro EO, Guerra C, Braga-Silva LA, Carvalho SM, Santos AL, et al. Cellular characterisation of Candida tropicalis presenting fluconazole-related trailing growth. Mem Inst Oswaldo Cruz. 2012;107(1):31\u20138.","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"11","key":"1074_CR21","doi-asserted-by":"publisher","first-page":"3532","DOI":"10.1128\/AAC.46.11.3532-3539.2002","volume":"46","author":"WL Smith","year":"2002","unstructured":"Smith WL, Edlind TD. Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation. Antimicrob Agents Chemother. 2002;46(11):3532\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"1074_CR22","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1128\/AAC.43.6.1383","volume":"43","author":"KA Marr","year":"1999","unstructured":"Marr KA, Rustad TR, Rex JH, White TC. The trailing end point phenotype in antifungal susceptibility testing is pH dependent. Antimicrob Agents Chemother. 1999;43(6):1383\u20136.","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"1074_CR23","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1128\/AAC.00420-08","volume":"52","author":"L Ostrosky-Zeichner","year":"2008","unstructured":"Ostrosky-Zeichner L, Rex JH, Pfaller MA, Diekema DJ, Alexander BD, Andes D, et al. Rationale for reading fluconazole MICs at 24 hours rather than 48 hours when testing Candida spp. by the CLSI M27-A2 standard method. Antimicrob Agents Chemother. 2008;52(11):4175\u20137.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"1074_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1128\/JCM.36.1.153-156.1998","volume":"36","author":"SG Revankar","year":"1998","unstructured":"Revankar SG, Kirkpatrick WR, McAtee RK, Fothergill AW, Redding SW, Rinaldi MG, et al. Interpretation of trailing endpoints in antifungal susceptibility testing by the National committee for clinical laboratory standards method. J Clin Microbiol. 1998;36(1):153\u20136.","journal-title":"J Clin Microbiol"},{"issue":"8","key":"1074_CR25","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1128\/AAC.44.8.2081-2085.2000","volume":"44","author":"BA Arthington-Skaggs","year":"2000","unstructured":"Arthington-Skaggs BA, Warnock DW, Morrison CJ. Quantitation of Candida albicans ergosterol content improves the correlation between in vitro antifungal susceptibility test results and in vivo outcome after fluconazole treatment in a murine model of invasive candidiasis. Antimicrob Agents Chemother. 2000;44(8):2081\u20135.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"1074_CR26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1093\/jac\/dkh040","volume":"53","author":"MK Lee","year":"2004","unstructured":"Lee MK, Williams LE, Warnock DW, Arthington-Skaggs BA. Drug resistance genes and trailing growth in Candida albicans isolates. J Antimicrob Chemother. 2004;53(2):217\u201324.","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"1074_CR27","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1128\/AAC.46.8.2477-2481.2002","volume":"46","author":"BA Arthington-Skaggs","year":"2002","unstructured":"Arthington-Skaggs BA, Lee-Yang W, Ciblak MA, Frade JP, Brandt ME, Hajjeh RA, et al. Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Candida isolates. Antimicrob Agents Chemother. 2002;46(8):2477\u201381.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"1074_CR28","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1439-0507.2006.01329.x","volume":"50","author":"MK Lee","year":"2007","unstructured":"Lee MK, Kim HR, Kang JO, Kim MN, Kim EC, Kim JS, et al. Susceptibility and trailing growth of Candida albicans to fluconazole: results of a Korean multicentre study. Mycoses. 2007;50(2):148\u20139.","journal-title":"Mycoses"},{"issue":"5","key":"1074_CR29","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1439-0507.2009.01733.x","volume":"53","author":"Z Odabasi","year":"2010","unstructured":"Odabasi Z, Paetznick VL, Rodriguez JR, Chen E, Rex JH, Leitz GJ, et al. Lack of correlation of 24- vs. 48-h itraconazole minimum inhibitory concentrations with microbiological and survival outcomes in a guinea pig model of disseminated candidiasis. Mycoses. 2010;53(5):438\u201342.","journal-title":"Mycoses"},{"issue":"3","key":"1074_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3390\/jof5030083","volume":"5","author":"U Binder","year":"2019","unstructured":"Binder U, Aigner M, Risslegger B, H\u00f6rtnagl C, Lass-Fl\u00f6rl C, Lackner M. Minimal inhibitory concentration (MIC)-phenomena in Candida albicans and their impact on the diagnosis of antifungal resistance. J Fungi (Basel). 2019;5(3):83.","journal-title":"J Fungi (Basel)"},{"issue":"1","key":"1074_CR31","doi-asserted-by":"publisher","first-page":"49.e1","DOI":"10.1016\/j.cmi.2016.09.016","volume":"23","author":"C Rueda","year":"2017","unstructured":"Rueda C, Puig-Asensio M, Guinea J, Almirante B, Cuenca-Estrella M, Zaragoza O, et al. Evaluation of the possible influence of trailing and paradoxical effects on the clinical outcome of patients with candidemia. Clin Microbiol Infect. 2017;23(1):49.e1-49.e8.","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"1074_CR32","doi-asserted-by":"publisher","first-page":"002046","DOI":"10.1099\/jmm.0.002046","volume":"74","author":"M Obermeier","year":"2025","unstructured":"Obermeier M, Esparza-Mora MA, Heese O, Cohen N, Varma SJ, Tober-Lau P, et al. Non-antifungal medications administered during fungal infections drive drug tolerance and resistance in Candida albicans. J Med Microbiol. 2025;74(7):002046.","journal-title":"J Med Microbiol"},{"issue":"8","key":"1074_CR33","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3390\/jof7080612","volume":"7","author":"P-Y Chen","year":"2021","unstructured":"Chen P-Y, Chuang Y-C, Wu U-I, Sun H-Y, Wang J-T, Sheng W-H, et al. Mechanisms of azole resistance and trailing in Candida tropicalis bloodstream isolates. J Fungi. 2021;7(8):612.","journal-title":"J Fungi"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-026-01074-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11046-026-01074-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-026-01074-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:18:54Z","timestamp":1781075934000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11046-026-01074-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1074"],"URL":"https:\/\/doi.org\/10.1007\/s11046-026-01074-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8484141\/v1","asserted-by":"object"}]},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"30 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"48"}}